Exercise does not activate the β3 adrenergic receptor-eNOS pathway, but reduces inducible NOS expression to protect the heart of obese diabetic mice

Basic Res Cardiol. 2016 Jul;111(4):40. doi: 10.1007/s00395-016-0559-0. Epub 2016 May 10.

Abstract

Obesity and diabetes are associated with higher cardiac vulnerability to ischemia-reperfusion (IR). The cardioprotective effect of regular exercise has been attributed to β3-adrenergic receptor (β3AR) stimulation and increased endothelial nitric oxide synthase (eNOS) activation. Here, we evaluated the role of the β3AR-eNOS pathway and NOS isoforms in exercise-induced cardioprotection of C57Bl6 mice fed with high fat and sucrose diet (HFS) for 12 weeks and subjected or not to exercise training during the last 4 weeks (HFS-Ex). HFS animals were more sensitive to in vivo and ex vivo IR injuries than control (normal diet) and HFS-Ex mice. Cardioprotection in HFS-Ex mice was not associated with increased myocardial eNOS activation and NO metabolites storage, possibly due to the β3AR-eNOS pathway functional loss in their heart. Indeed, a selective β3AR agonist (BRL37344) increased eNOS activation and had a protective effect against IR in control, but not in HFS hearts. Moreover, iNOS expression, nitro-oxidative stress (protein s-nitrosylation and nitrotyrosination) and ROS production during early reperfusion were increased in HFS, but not in control mice. Exercise normalized iNOS level and reduced protein s-nitrosylation, nitrotyrosination and ROS production in HFS-Ex hearts during early reperfusion. The iNOS inhibitor 1400 W reduced in vivo infarct size in HFS mice to control levels, supporting the potential role of iNOS normalization in the cardioprotective effects of exercise training in HFS-Ex mice. Although the β3AR-eNOS pathway is defective in the heart of HFS mice, regular exercise can protect their heart against IR by reducing iNOS expression and nitro-oxidative stress.

Keywords: Cardioprotection; Exercise; Insulin resistance; Myocardial infarction; Nitric oxide; Type 2 diabetes; β3-Adrenergic receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Ischemia / metabolism
  • Myocardial Reperfusion Injury / metabolism*
  • Nitric Oxide Synthase Type II / biosynthesis*
  • Nitric Oxide Synthase Type III / metabolism
  • Obesity / complications*
  • Physical Conditioning, Animal / physiology*
  • Receptors, Adrenergic, beta-3 / metabolism

Substances

  • Receptors, Adrenergic, beta-3
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III